SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006274
Filing Date
2020-05-11
Accepted
2020-05-11 16:32:38
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20200511x10q.htm   iXBRL 10-Q 1983217
2 EX-10.1 cara-20200331xex10d1.htm EX-10.1 23712
3 EX-31.1 cara-20200331xex31d1.htm EX-31.1 15253
4 EX-31.2 cara-20200331xex31d2.htm EX-31.2 15555
5 EX-32.1 cara-20200331xex32d1.htm EX-32.1 12869
  Complete submission text file 0001558370-20-006274.txt   7970564

Data Files

Seq Description Document Type Size
6 EX-101.SCH cara-20200511.xsd EX-101.SCH 52167
7 EX-101.CAL cara-20200511_cal.xml EX-101.CAL 59056
8 EX-101.DEF cara-20200511_def.xml EX-101.DEF 238497
9 EX-101.LAB cara-20200511_lab.xml EX-101.LAB 506615
10 EX-101.PRE cara-20200511_pre.xml EX-101.PRE 409261
13 EXTRACTED XBRL INSTANCE DOCUMENT cara-20200511x10q_htm.xml XML 1398153
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 20865353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences